Medical Cannabis and Cannabinoids in Cancer Treatment

57 minute read
0
(0)

Medical cannabis does not treat cancer itself. In clinical studies it helped some people with chemotherapy nausea, and it is being studied for cancer pain, appetite loss, sleep and worry. It works alongside your cancer treatment, never instead of it, and the decision to try it belongs in a conversation with your oncologist.

Medical cannabis and cancer at a glance

Here is the short version of what the research says for people living with cancer. Each point is explained further down the page, with its sources.

  • Chemo nausea

    The clearest signal. In randomized trials, a THC:CBD extract added to standard anti-nausea medicines lowered nausea for some patients compared with placebo [1][2].

  • Cancer pain

    Some reviews see a modest benefit, but the certainty of that evidence is very low and results against placebo are mixed [3].

  • Appetite and weight

    THC-based prescription medicines exist for appetite problems in some conditions; for cancer weight loss the human data is still thin [4].

  • Sleep, anxiety and mood

    In a state-program cohort, anxiety and depression scores improved more in people taking cannabis by mouth [5].

  • The tumor itself

    Effects on cancer cells come from lab and animal studies only. They have not been shown to shrink tumors in people [6].

  • Safety and your medicines

    Cannabis can change how the liver handles opioids, antidepressants, blood thinners and some chemotherapy drugs, so your care team needs to know [7].

Can you get a card for cancer?

Start where you are

Living with cancer symptoms: pain, nausea and appetite loss

Cancer and its treatment often bring symptoms that wear you down long before the scans change: pain that comes in waves, nausea on infusion days, meals that stop tasting like anything, nights without real sleep. These symptoms are common, they are real medical problems, and they deserve treatment of their own.

Does cancer cause pain?

Often, yes. The National Cancer Institute calls pain one of the most common symptoms in people with cancer. It can come from the tumor pressing on bones, nerves or organs, from treatment itself (surgery, nerve damage from chemotherapy, mouth sores, skin irritation from radiation), and even from tests and procedures. Pain can also continue after treatment ends [8].

Doctors record this kind of pain with its own diagnosis code in the U.S. ICD-10-CM system, the classification used on medical records and insurance claims: neoplasm-related pain, code G89.3 [9]. Having it written down matters, because it makes the pain part of your official care plan.

  • Pain from the tumor, surgery, nerve damage or radiation, sometimes lasting after treatment.

  • Nausea and vomiting around chemotherapy, which can make it hard to keep food and fluids down.

  • Appetite loss and changes in taste that lead to unplanned weight loss.

  • Fatigue that rest does not fix, the most draining symptom for many people.

  • Poor sleep and anxiety that feed each other, especially between scans and appointments.

Why do people with cancer lose weight and appetite?

Some weight loss comes from eating less: nausea, mouth sores and taste changes all get in the way. But cancer can also cause cachexia, a wasting syndrome in which the body loses fat and muscle and grows weak even when a person is eating [10]. That is why “just eat more” rarely solves it, and why appetite is treated as a medical problem, not a matter of willpower.

When standard medicines aren’t enough

Anti-nausea medicines and pain relievers work well for many people, yet not for everyone. Some patients still feel sick on chemotherapy days despite their prescriptions. Opioids can relieve pain but bring constipation, drowsiness and worries about dependence. Sleep aids can leave a heavy, foggy morning.

This gap is where cannabinoids, the active compounds in cannabis, have been studied: not as a cancer treatment, but as supportive care added to standard medicines. The next sections show where that research is solid, where it is thin, and what it means for you.

Nausea and medical cannabis

Cancer basics: symptoms, staging and common myths

Cancer is a disease in which some of the body’s cells grow uncontrollably and can spread to other parts of the body [11]. Below are plain answers to the questions people search most often after a diagnosis, before we turn to cannabis.

  • Common cancer symptoms

    Symptoms depend on where the cancer is and how it is treated. Many of them can also have everyday causes, so a symptom on this list is a reason to ask a doctor, not a diagnosis.

    • Unexplained weight loss or loss of appetite [10]
    • Fever or frequent infections, especially during chemotherapy [12]
    • Tiredness from anemia (a low red blood cell count)
    • Diarrhea or other bowel changes from treatment
    • Hair loss during some chemotherapy
    • Easy bruising or bleeding when blood counts are low
  • How cancer forms and spreads

    Cancer starts with genetic changes in cells that control how they grow and divide. These changes can come from errors as cells divide, from damage such as tobacco smoke or UV radiation, or can be inherited. When cancer spreads to distant parts of the body it is called metastasis, and it keeps the name of the original cancer [11].

  • How cancer is staged

    Most cancers are staged with the TNM system: the size of the main tumor (T), whether nearby lymph nodes are involved (N), and whether it has spread (M). Stages run from 0 to IV; stage IV means the cancer has reached distant parts of the body. A cancer keeps the stage given at diagnosis, even if it changes later [13].

  • Cancer-free vs. remission

    Remission means signs and symptoms of cancer have decreased (partial) or disappeared (complete). Doctors are careful with “cancer-free” or “cured,” because some cancers can return years later. That is why follow-up scans continue after treatment ends, and why fear of recurrence is so common.

  • Is cancer terminal or chronic?

    It depends on the type and stage. Many cancers found early are treated with the aim of cure. Others are managed for years like a chronic illness, with treatment that keeps them under control. “Terminal” is used only when a cancer can no longer be controlled, and your oncologist is the right person to explain where your situation sits.

  • Can cancer be transmitted? Is it a parasite or a virus?

    No. Cancer is not contagious and does not spread from person to person. Some viruses and bacteria that raise cancer risk can pass between people, but the cancers they cause cannot. Cancer is not a parasite either: it is the body’s own cells growing out of control [14].

Common symptom questions are in the FAQ

Could medical cannabis fit into your cancer care?

Twelve short questions about your diagnosis, treatment, symptoms and medicines. You get a plain summary of what the research says for a situation like yours and what to bring to your oncologist.

12 questions · about a minute · your answers stay in this browser

Question 1 of 12

Right now, do you have any of these: a fever of 100.5°F or higher during chemotherapy, vomiting so bad you cannot keep fluids down, pain that is suddenly out of control, or new confusion?

These need your oncology team or emergency care first, before anything else.

How does cannabis work in the body?

Cannabis works through the endocannabinoid system, a signaling network your body already has. It helps regulate pain, nausea, appetite, mood, sleep and immune activity, which is exactly why cannabinoids are studied for the symptoms of cancer and its treatment [3].

How it works in general, not a treatment claim.

  1. 1

    Receptors and the compounds that fit them

    Cannabinoids attach to receptors like a key in a lock. CB1 receptors sit mostly in the brain and nerves, where they change pain and nausea signals. CB2 receptors sit mostly on immune cells.

  2. 2

    THC and CBD act differently

    THC causes the “high” and drives most effects on nausea, appetite and pain. CBD does not cause a high and acts on other targets. A result found for one does not carry over to the other.

  3. 3

    The form changes the path

    Inhaled cannabis reaches the blood within minutes. Swallowed products pass through the liver first, start later and last longer, and that liver step is where many drug interactions happen.

The two main compounds also shape each other. A 2025 systematic review and meta-analysis of cannabinoids for cancer symptoms notes that CBD tapers down the psychoactive effect of THC, which is one reason many products and trial medicines combine them [3]. Food matters too: a high-fat meal can raise how much CBD the body absorbs by up to four times [15], so the same product can feel different with and without a meal.

Other plant compounds, such as terpenes, may add to these effects, but how much they matter in people is not yet known.

The endocannabinoid system, explained

Symptom relief: where is the evidence stronger?

The strongest human evidence is for chemotherapy nausea. Pain, appetite, sleep and mood have been studied too, with weaker or mixed results. This table shows what was tested and what kind of study tested it.

What was studied for cancer symptoms
SymptomWhat was testedType of evidenceSource
Chemotherapy nausea and vomitingOral THC:CBD extract added to standard anti-nausea medicines, against placeboRandomized trial[1][2]
Cancer painCannabinoids for cancer-associated symptoms, pooled across studiesMixed results[3]
Overall symptom burden in advanced cancer1:1 THC:CBD oil against placebo in palliative careRandomized trial[16]
Anxiety and depressionProducts taken by mouth vs. other forms in a state medical cannabis programObservational[5]
Joint and muscle pain from breast cancer hormone therapyCBD in a small pilot study without a placebo groupMixed results[17]
Dry mouth, swallowing and well-being in head and neck cancerSupportive-care use summarized in a narrative reviewMixed results[7]

Does cannabis help with chemotherapy nausea?

For some people, yes, when it is added to standard anti-nausea medicines rather than used instead of them. Two placebo-controlled trials point the same way.

Nausea score with THC:CBD vs. placebo

2.11 vs 2.99 [1]

Average nausea score on THC:CBD extract compared with placebo, in a randomized, double-blind crossover trial of 54 women receiving chemotherapy. The extract was taken on top of standard nausea prevention; a lower score means less nausea [1] (2023).

A phase II/III randomized trial of oral THC:CBD in people whose nausea continued despite standard medicines found a complete response about three times as often as with placebo: RR 3.0, likely range 1.0 to 7.0 [2] (2024).

Both trials were small, and the lower end of the second range touches “no difference.” Talk with your oncologist before adding anything to your anti-nausea plan.

Dronabinol and nabilone, two prescription cannabinoid medicines, are already FDA-approved for nausea from chemotherapy [4]. The difference between those and products from a dispensary is explained further down.

Can cannabis help with cancer pain?

Possibly a little, for some people, but the evidence is weak. A 2025 systematic review and meta-analysis found a signal for lower cancer-associated pain, rated the certainty of that evidence as very low, and recorded more psychiatric, neurological and stomach side effects with THC-heavy products [3]. Cannabis is best thought of as a possible add-on to a pain plan your care team manages, not a replacement for it.

If you take opioids, the combination can deepen drowsiness and slow thinking. Bring this up before you start, not after.

Why do people with cancer lose appetite, and can cannabis help?

Appetite loss comes from nausea, taste changes, pain, low mood and cachexia, the wasting syndrome described above [10]. THC is known to stimulate appetite, and dronabinol is FDA-approved for appetite loss with weight loss in people with AIDS [4]. For cancer-related weight loss, the human data in our sources is still too thin to promise results. Read more about appetite loss and medical cannabis.

Sleep, anxiety and quality of life

Here the picture is honest but uneven. In a long-term cohort of people with cancer in a state medical cannabis program, those who took products by mouth reported greater improvement in anxiety (mean difference 1.53 points, likely range 1.38 to 1.68) and depression (1.36 points, 1.22 to 1.51) than those who did not [5] (2025). This was an observational study, so it shows a link, not proof that cannabis caused the change.

A randomized trial gives the counterweight. In advanced cancer, a 1:1 THC:CBD oil did not improve the overall symptom distress score compared with placebo: the difference was −0.33 points, p = 0.91 [16] (2025). A neutral result like this is as important to know as a positive one.

Low risk: side effects in the trials were mostly manageable

In the nausea trials, the most common complaints were dizziness and sleepiness, which most participants tolerated [1]. Effects still depend on the person, the product and the other medicines you take.

On chemo or immunotherapy? Check interactions first

Cannabis and cancer: what does the research say?

Research on cannabis and cancer splits into two very different questions. Can it ease symptoms? There are human trials, and some are encouraging. Can it treat the cancer itself? So far that evidence comes from lab dishes and animals, not from people. The table runs from the strongest claim to the weakest.

Common claims and the evidence behind them
ClaimType of dataHow strong
Relieves chemotherapy nausea when added to standard medicinesRandomized trials in people [1][2]Moderate
Eases cancer painSystematic review and meta-analysis [3]Very low certainty
Improves overall symptom burden in advanced cancerRandomized trial, no difference from placebo [16]Not shown
Improves appetite and weight in cancerPrescription THC approved for other conditions; little cancer data [4]Unclear
Slows or kills tumorsIn lab and animal studies only [6][15]Not tested in people
Lowers cancer riskObservational studies only; links, not causes [18]Not shown

An ASCO Educational Book review of integrative oncology for gastrointestinal cancers places cannabinoids where the evidence puts them: as one option for symptoms, used alongside standard care and discussed with the oncology team [19].

Explore the studies behind this page

Pick a study type to see how much of what you may have heard was actually tested in people. Neutral and negative results are shown as plainly as positive ones.

  • 2024 · Randomized trial, phase II/III

    Oral THC:CBD for chemotherapy nausea that standard medicines did not control

    Adults whose nausea and vomiting continued despite guideline anti-nausea medicines, THC:CBD capsules vs. placebo.

    Complete response was more likely with THC:CBD: RR 3.0 (likely range 1.0 to 7.0) [2].

  • 2023 · Randomized crossover trial

    THC:CBD extract added to standard nausea prevention

    54 women receiving chemotherapy, each tried both extract and placebo [1].

    Average nausea score 2.11 with extract vs. 2.99 with placebo; dizziness or sleepiness in 36 of 54 [1].

  • 2025 · Randomized trial

    1:1 THC:CBD oil for symptom control in advanced cancer

    Adults with advanced cancer receiving palliative care, oil vs. placebo.

    No difference in overall symptom distress: −0.33 points, p = 0.91 [16].

  • 2025 · Systematic review and meta-analysis

    Cannabinoids for the palliation of cancer-associated symptoms

    Pooled studies of cannabinoids for pain, anxiety and other symptoms.

    A signal for pain and anxiety relief, more side effects with THC-heavy products; certainty very low [3].

  • 2026 · Narrative review

    Medical cannabis in supportive care for head and neck cancers

    Summary of supportive-care use in a group with heavy treatment side effects.

    Possible help with symptoms, plus warnings on liver-enzyme interactions and blood thinners [7].

  • 2025 · Narrative review

    Cannabinoids and outcomes on immune checkpoint inhibitors

    People receiving immunotherapy, such as PD-1 inhibitors.

    Mixed findings: some studies link cannabis use with poorer outcomes, so timing and use need a talk with the oncologist [20].

  • 2025 · ASCO Educational Book review

    Integrative oncology for gastrointestinal cancers

    Guidelines and evidence on complementary approaches in GI cancer care.

    Places cannabinoids among symptom options used alongside, not instead of, standard treatment [19].

  • 2025 · Pilot clinical trial, single group

    CBD for joint and muscle pain from aromatase inhibitors

    Postmenopausal women with breast cancer on hormone therapy; no placebo group.

    Mixed results; CBD may also lower blood levels of anastrozole through the CYP3A4 liver enzyme [17].

  • 2025 · Cohort study

    Cannabis, anxiety and depression in a state medical program

    People with cancer followed over time in a medical cannabis program.

    Anxiety and depression improved more with products taken by mouth; a link, not proof [5].

  • 2026 · Prospective cohort study

    Cannabis use, opioid use and complications after cancer surgery

    A small group of adults having abdominal cancer surgery, regular users compared with non-users.

    Complications were recorded in 5 of 23 users and 21 of 41 non-users; the study was too small to show cause, and its overall result was not in favor of cannabis [21].

  • 2026 · Retrospective cohort study

    Cannabis use disorder and pancreatic cancer in chronic pancreatitis

    Health records of people with chronic pancreatitis, with and without cannabis use disorder.

    Pancreatic cancer was recorded less often (HR 0.263), but pancreatitis flares more often (HR 1.102). An association, not a cause [18].

  • 2024 · Trial protocol

    MedCan 3: THC/CBD 1:20 for symptom burden in cancer

    A placebo-controlled trial planned for 150 participants [22].

    Results not yet published [22].

  • 2025 · Systematic review, mostly lab and animal work

    Cannabinoids against gliomas

    Recent research on brain tumors, almost all in cells and animals.

    Anti-tumor effects in lab and animal studies; evidence certainty very low and not tested as treatment in people [6].

  • 2026 · Narrative review

    CBD in gliomas and new ways to deliver it

    Lab and animal research on CBD and drug carriers.

    In lab models, CBD added to temozolomide’s effect on tumor cells; no proof of benefit in patients [15].

  • 2025 · Narrative review

    Cannabinoids and cervical cancer treatment

    Preclinical studies combining cannabinoids with chemotherapy.

    In lab studies, effects alongside cisplatin; a lab-based concern that cannabinoids could dampen immune cells that immunotherapy relies on [23].

What this means for specific cancers

Cannabis and specific cancer types: what has been studied

For most cancer types, research on cannabis is still in the lab. Where people were studied, it was usually for symptoms or side effects of treatment, not for the tumor. Here is where each type stands.

  • Glioma and other brain tumors

    Lab and animal studies

    Brain tumors are the most studied type. In lab and animal studies, CBD and THC slowed tumor cells and added to the effect of temozolomide and radiation [6][15]. None of this has been shown as a treatment in people.

  • Breast cancer

    Small clinical study

    A pilot study tested CBD for the joint and muscle pain that aromatase inhibitors can cause. Results were mixed, and CBD may lower anastrozole levels, which makes this a question for your oncologist [17].

  • Head and neck cancers

    Review of supportive care

    Treatment here often brings mouth pain, dry mouth and trouble swallowing. A review describes cannabis as a possible part of supportive care, with care around drug interactions [7].

  • Pancreatic cancer

    Observational

    In people with chronic pancreatitis, those with cannabis use disorder had pancreatic cancer recorded less often (HR 0.263, likely range 0.202 to 0.344) but more pancreatitis flares (HR 1.102) [18]. This is a link in health records, not a cause, and not a reason to use cannabis.

  • Cervical cancer

    Lab studies

    A review of preclinical work describes effects of cannabinoids on cervical cancer cells and alongside cisplatin in the lab [23]. Human data is lacking.

  • Gastrointestinal cancers

    Clinical review

    An ASCO review of integrative oncology for GI cancers covers cannabinoids as a symptom option within standard care [19].

Key takeaway

No cancer type has human evidence that cannabis cures it or shrinks it. What people were studied for is symptom relief during treatment.

What science doesn’t know yet

Ways to use cannabis during cancer treatment: what matters for each form

Cannabis is not the same thing as smoking it. Edibles, capsules, tinctures, sprays, creams and patches all exist, and each one changes what you need to think about during treatment. It helps to sort the risks into three layers.

  • 1. Smoke and vapor

    Smoke and hot vapor pass over the mouth, throat and lungs. That matters with mouth sores from chemotherapy, radiation to the head, neck or chest, or lung cancer. The CDC notes that smoked cannabis, however it is smoked, can harm lung tissue and blood vessels [24].

  • 2. Any form

    Whatever the form, THC still acts on the brain, swallowed and held products still pass through the liver, and interactions, drowsiness and impaired driving still apply [7]. Choosing a form without smoke does not remove these.

  • 3. Shared devices

    A shared joint, pipe or vape passes germs between people. When chemotherapy lowers your white blood cells, infections can become dangerous quickly [12].

Forms of cannabis and what applies to each
FormHow it entersStarts and lastsWhat it avoidsWhat still applies
Smoking: joints, pipes, bongsBurned plant, through the lungsWithin minutes; shorterThe liver’s first passSmoke on mouth, throat and lungs; THC effects; interactions
Vaping and dabbingHeated aerosol, through the lungsWithin minutes; shorterBurningHot aerosol on the same airways; strong concentrates; interactions
Edibles, beverages and capsulesSwallowed, through the gut and liverLater; longerSmoke and vapor; shared mouthpiecesDelayed effect, liver processing, interactions, drowsiness
Tinctures, oils and mouth spraysUnder the tongue or inside the cheek; part is swallowedIn between; variesSmoke and vaporThe swallowed part passes through the liver; interactions
Topicals and patchesCreams act on the skin; patches reach the bloodVaries by productSmoke, vapor and the gutPatches still carry cannabinoids into the blood; skin on radiation sites
FDA-approved prescriptionsCapsules or oral solutionSet by the labelUnknown product contentPrescription medicine with its own label; see below

Moderate risk: edibles act late

Swallowed cannabis can take a long time to start working. Taking a second dose because “the first one didn’t work” is a common cause of taking too much. Which form fits your treatment is a question for your doctor, not for this page.

Dosing medical cannabis: how doctors think about it

FDA-approved cannabinoids vs. medical cannabis: what’s the difference?

Prescription cannabinoids are FDA-approved medicines with a fixed dose; medical cannabis is a plant product you buy at a licensed dispensary with a state card. Both can be part of cancer care, and they are not interchangeable [4].

Prescription cannabinoids compared with medical card products
AspectPrescription: dronabinol (Marinol, Syndros), nabilone (Cesamet)Medical card products
What it isSynthetic THC (dronabinol) or a THC-like compound (nabilone) in a fixed dosePlant-based products with varying THC, CBD and other compounds
Approved usesNausea and vomiting from cancer chemotherapy; dronabinol also for appetite loss in AIDS [4]Not FDA-approved; state programs list the conditions they cover
How the dose is setBy the prescriber, following the labelDiscussed with the recommending physician; product labels and lab tests guide content
InsuranceMay be covered like other prescriptionsUsually paid out of pocket
How you get itPrescription filled at a pharmacyPhysician recommendation, state registration where required, then a licensed dispensary

Many people find it useful to raise both options at the same visit. Ask your oncologist whether a prescription cannabinoid makes sense for your nausea or appetite, and if you are considering medical cannabis, how it would fit with your other medicines. Two prescription options sit next to each other here because they are the only ones the FDA has approved for these uses; no other cannabis or CBD product on the market is FDA-approved [4].

Medical vs. recreational cannabis

What science doesn’t know yet: limitations and evidence gaps

A lot is still not yet known, and saying so plainly is part of a fair answer. These are the main limitations and evidence gaps, and each one needs further research before anyone can promise more.

  • The newest trials are not finished. MedCan 3, a placebo-controlled trial of THC/CBD 1:20 for cancer symptom burden, has published its plan but not its results [22].
  • The nausea trials were small. In one, patients’ starting nausea scores were low, around 2 out of 10, and the authors point to possible placebo effects and fixed doses as limits [1].
  • There are no standard doses for people with cancer. Trials used different products, ratios and schedules, so their results cannot simply be added together [3].
  • Most anti-tumor research has not reached people. Much of it is in cells and animals, and some lab work has never been tested in living organisms [6].
  • Effects on immunotherapy are unsettled. Findings so far are mixed and largely based on lab models and retrospective data [20][23].

What kinds of studies are behind these findings?

How to read it: each row is one type of study. The bar length and the number on the right show how many published works of that type exist on cannabis and cancer. Types near the top are better at showing cause and effect; gray rows are studies without patients.

  • Meta-analyses and systematic reviews60
  • Randomized trials44
  • Other clinical trials36
  • Cohort and case-control studies216
  • Surveys and cross-sectional studies211
  • Case reports58
  • Narrative reviews and guidelines624
  • Animal studies160
  • Cell studies405
Randomized trials are few; studies on cells and animals outnumber them many times over. That is why this page talks about symptom relief and not about treating the tumor.
Show as a table
Type of studyPublished worksIncludes patients
Meta-analyses and systematic reviews60Summarizes other studies
Randomized trials44Yes
Other clinical trials36Yes
Cohort and case-control studies216Yes
Surveys and cross-sectional studies211Yes
Case reports58Yes
Narrative reviews and guidelines624Summarizes other studies
Animal studies160No
Cell studies405No

The future of cannabis and cancer care

The future of cannabis and cancer care

The next few years should bring clearer answers on symptoms rather than headlines about cures. Research is moving toward larger placebo-controlled trials for chemotherapy nausea, appetite loss and cachexia, and symptom control in palliative care, with standardized products whose THC and CBD content is known. Researchers are also asking how cannabinoids interact with immunotherapy and other cancer drugs, a question that matters for many people in treatment today [20].

Trials to watch

  • MedCan 3

    What it tests: an oral THC/CBD 1:20 product against placebo for overall symptom burden in people with cancer, planned for 150 participants [22].

    Status: protocol published; results not yet published.

  • 1:1 THC:CBD in palliative care

    What it tests: a balanced THC:CBD oil against placebo for symptom burden in advanced cancer [25].

    Status: completed; no difference from placebo on the main symptom score [16].

Until those answers arrive, the most useful step is the same as today: an open conversation with your care team about what you hope cannabis might help with and what you already take.

Who reviews this page

Safety and side effects: what to watch for

Most side effects reported in cancer studies were mild to moderate, but THC and CBD cause different ones, and smoke adds its own. The table sorts them by what they were reported with.

Side effects and what they were reported with
EffectReported withNote
Dizziness or sleepinessTHC:CBDReported by 36 of 54 participants in a chemotherapy nausea trial [1]
Drowsiness, dry mouth, slowed thinking, euphoriaTHCCommon; avoid driving while affected [3]
Fatigue, diarrhea, appetite changesCBDCommon in CBD studies [3]
Anxiety, paranoia, confusion, mood changesTHC-heavy productsMore likely with higher THC and in people with psychiatric history [3]
Fast heartbeat, higher blood pressureTHCMatters with heart disease; trials excluded people with unstable heart conditions [22]
Cough, throat and lung irritationSmoking and vaping onlyNot from edibles, tinctures or topicals [24]

When nausea gets worse: cannabinoid hyperemesis syndrome

Some people who use cannabis heavily over a long time develop cycles of severe nausea and vomiting, often eased for a while by hot showers. This is cannabinoid hyperemesis syndrome. It can look like ordinary chemotherapy nausea, so if your nausea keeps getting worse while you use cannabis, tell your care team. Stopping cannabis is what resolves it.

Call your care team right away if

  • Confusion or paranoia that does not pass as the effect wears off.

  • A racing heart or chest pain after using cannabis.

  • Vomiting that won’t stop and you cannot keep fluids down.

  • A fever during chemotherapy, 100.5°F or higher, even if you feel otherwise fine [12].

Interactions with your cancer treatment

Cannabis and your cancer treatment: interactions to discuss with your oncologist

Cannabis can change how other medicines work, mostly through the liver enzymes that break drugs down. Some of these interactions are known from patients, some from drug chemistry, and some only from the lab. Each card says which.

Opioids, antidepressants and chemotherapyDrug-level

Cannabis can act on liver enzymes (the CYP family) that process many drugs, which can raise or lower their levels in the blood [7]. With opioids, extra drowsiness adds to that.

CYP3A4 drugs, such as anastrozoleDrug-level

CBD blocks the CYP3A4 enzyme, which could lower blood levels of anastrozole, a breast cancer hormone therapy, or change other medicines that use the same pathway [17].

Warfarin and other blood thinnersClinical

CBD may raise the risk of side effects from anticoagulants, and warfarin needs monitoring when cannabis is added [7][5]. Blood clots are common in cancer, so many patients take these drugs.

Buprenorphine and tacrolimusClinical

Both were flagged as possible interactions that need monitoring in people with cancer using medical cannabis [5].

Immunotherapy (PD-1 inhibitors)Lab

In lab work, cannabinoids acting on CB2 receptors can dampen T cells, the immune cells that immunotherapy depends on [23]. Studies in patients are mixed, with some linking cannabis use to poorer outcomes [20]. If you are on immunotherapy, ask about timing before you start.

Chemotherapy and radiation in lab modelsLab

In cells and animals, cannabinoids added to the effect of temozolomide and cisplatin and made tumor cells more sensitive to radiation [15][23][6]. These are lab findings and should not be carried over to people: they are not a reason to combine cannabis with your treatment.

How to bring it up with your oncologist

Many patients worry the topic will be brushed off. It usually helps to come prepared, so the conversation is about your treatment and not about cannabis in general.

  1. Bring a list of every medicine and supplement you take, including over-the-counter ones.
  2. Say which form you use or are considering, and how often.
  3. Name the symptom you hope it helps: nausea, pain, appetite, sleep or worry.
  4. Mention the date of your next chemotherapy, immunotherapy or surgery.
  5. Ask whether it is safe for you to drive, and on which days.

Mixing cannabis and ibuprofen

Who should avoid cannabis during cancer care?

For some people the risks outweigh any likely benefit, and clinical trials leave them out on purpose. If one of these describes you, talk with your oncologist before using any cannabis product.

  • Unstable or untreated heart disease. Cancer trials excluded these patients [22].

  • Severe liver or kidney problems. Also excluded from trials, since the liver processes cannabinoids [22].

  • A history of severe psychiatric illness or substance use disorder. THC can worsen both [22].

  • Pregnancy or breastfeeding. Trials required avoiding both [25].

  • A weakened immune system. Low white blood cells make any infection more dangerous, including from shared devices [12].

  • Driving or operating machinery. Trial participants were told not to while taking cannabinoids [22].

  • Bowel obstruction or recent radiation therapy. Listed among exclusions in a palliative care trial [25].

High risk: when cannabis is the wrong step right now

A fever during chemotherapy, vomiting you cannot stop, pain that is suddenly out of control, or new confusion all need your oncology team or emergency care first. Cannabis never replaces or delays chemotherapy, radiation, surgery or immunotherapy: delaying proven treatment can have serious consequences.

Is cancer a qualifying condition for a medical marijuana card?

In most state medical cannabis programs, yes: cancer is named directly on the list of qualifying conditions. Some states list it through its symptoms instead, such as severe nausea, chronic pain or cachexia (wasting). Each state writes and updates its own list, so the exact wording depends on where you live [26].

What usually counts is a documented diagnosis, current or past, and symptoms that affect your daily life. You do not need to be in active treatment, and a card does not replace anything your oncologist prescribes. Rules on registration, possession and renewal are set by your state; our overview of state cannabis laws collects them in one place.

To prepare for the evaluation, keep these at hand:

  • Your diagnosis in writing: a pathology report, an oncology visit summary or a discharge note.
  • A list of current medicines, including chemotherapy, immunotherapy, pain relievers and blood thinners.
  • The symptoms you want help with, and what you have already tried.

Not sure what happens during the appointment? Read how the evaluation works.

How to get a medical marijuana card for cancer

You can do it from home in four steps. Two of them are ours to keep short; the last one belongs to your state.

  1. Step 1

    Fill out a short form

    Tell us your state, your diagnosis and your symptoms. It takes about five minutes.

  2. Step 2

    Meet a physician licensed in your state

    A one-on-one appointment of about fifteen minutes, all online. You agree on the time with the doctor; keep the hour free, not just the minute.

  3. Step 3

    Receive your signed recommendation

    If the doctor finds you qualify, the signed recommendation usually arrives within 24 to 48 hours after the appointment.

  4. Step 4

    Register with your state program

    Where your state requires registration, you submit the recommendation to the state program. Review times are set by the state agency.

After you book

You will get a confirmation email; if it is not in your inbox, check the spam folder. Your recommendation and appointment details stay in your account and documents, so you can find them again when you register with the state or renew.

4.6out of 5 on Google

Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.

  • 150,000+patients evaluated — everyone who has been through an appointment with us, in every state where we are licensed
  • Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side

Questions about the process are answered in our medical card FAQ. Veterans can read about support for veterans, and people on a limited income can see our low-income program.

Renewing your card during ongoing cancer care

Cards expire, and treatment often lasts longer than one card. How long a card is valid and how renewal works are set by each state, so check the date on yours and your state’s rules ahead of time.

Renewal is a new evaluation, which makes it a good moment to update the doctor. If your treatment has changed since the last visit, say so: a new chemotherapy, the start of immunotherapy, surgery coming up, or new medicines such as blood thinners or opioids. The interactions above can shift with each change.

Lost or damaged card? Here is what to do if your medical card was lost.

Set a reminder a month before your card expires

Treatment weeks are unpredictable. A month gives you room to schedule the appointment around infusions and recovery days.

How state medical programs and dispensaries work

A medical cannabis program is run by your state. A physician’s recommendation shows you qualify; in many states you then register with the program and receive a patient card, which lets you buy from licensed dispensaries within the state’s limits [26]. Many programs also allow a registered caregiver to buy on behalf of a patient who cannot go alone; the rules for this are part of each state’s law.

Buy only from dispensaries licensed by your state, which publishes them through its program. Licensed products are labeled with their THC and CBD content and tested by a lab, which matters more when your immune system is weakened.

Traveling? Some states honor cards from other states, many do not; see which states accept out-of-state medical cards and traveling with medical cannabis. Medical patients may also pay different taxes than recreational buyers: medical vs. recreational cannabis taxes.

What to ask at the dispensary

  1. How much THC and CBD is in this product, and in what ratio?
  2. What form is it, and is there a version without smoke?
  3. Can I see the lab test for this batch?
  4. How long does it take to start working, and how long does it last?

Cannabis laws by state

Cannabis and cancer: questions patients ask

About cannabis and cancer

Can cannabis cure cancer?

No. There is no human evidence that cannabis or cannabinoids cure cancer. Anti-tumor effects have been seen only in lab and animal studies, which often do not hold up in people [6][15]. Cannabis should never replace or delay chemotherapy, radiation, surgery or immunotherapy. What it may offer is relief from some symptoms during treatment.

Is cannabis safe for cancer patients?

For many people, side effects are manageable: dizziness and sleepiness were the most common in a chemotherapy nausea trial [1]. But cannabis can interact with chemotherapy, opioids, antidepressants and blood thinners through liver enzymes [7], and it is not advised with unstable heart disease, severe liver problems, pregnancy or certain psychiatric conditions. Safety depends on your situation, so ask your oncologist.

Can cannabis help manage cancer-related symptoms?

For some symptoms and some people, yes. The best evidence is for chemotherapy nausea when cannabis is added to standard medicines [2]. Evidence for pain is of very low certainty [3], and a trial in advanced cancer found no overall difference from placebo [16]. Think of it as a possible add-on to your care plan, not a fix.

Are CBD and THC different in cancer treatment?

Yes. THC causes the high and drives most effects on nausea, appetite and pain, along with drowsiness and confusion. CBD does not cause a high, tapers down THC’s psychoactive effect [3], and has its own side effects such as fatigue and diarrhea. CBD also blocks a liver enzyme that processes some cancer drugs [17]. Results for one do not apply to the other.

Can cannabis interact with my cancer treatment?

Yes, it can. Cannabis affects liver enzymes that process many chemotherapy drugs and supportive medicines [7]. CBD may lower levels of anastrozole [17], and some studies link cannabis use during immunotherapy to poorer outcomes [20]. Share everything you take with your oncologist; the interactions section lists what to raise.

What are the side effects of cannabis in cancer patients?

The most common are dizziness, sleepiness, dry mouth and slowed thinking with THC, and fatigue, diarrhea or appetite changes with CBD. THC-heavy products can also cause anxiety, paranoia or a fast heartbeat [3]. Smoke and vapor add cough and throat irritation. Report any side effect to your care team, especially confusion or vomiting that will not stop.

Should I discuss cannabis use with my doctor?

Yes, always, and ideally before you start. Your oncologist knows your treatment schedule, blood counts and other medicines, which are exactly the things that decide whether cannabis is safe for you. Bring a full medicine list and the symptom you want help with; the five questions above make the talk easier. Doctors hear this question often.

Is it safe to use cannabis to help with pain while on opioids?

It can be, under medical supervision, but the combination adds drowsiness and slowed thinking, and cannabis can change how the liver handles opioids [7]. Evidence that cannabis improves cancer pain is of very low certainty [3]. Never lower your opioid dose on your own; changes to a pain plan belong with the doctor who manages it.

Are there specific types of cancer that respond better to cannabinoids?

Not in people. Brain tumors such as glioma are the most studied, but almost entirely in cells and animals [6]. No cancer type has human evidence that cannabinoids treat the tumor. Where people were studied, it was for symptoms and side effects, which you can see by type in the specific cancer types section.

Are there risks to using cannabis that can be passed down to future generations?

This is not settled. Some researchers suggest heavy, long-term THC use might affect sperm and eggs, but evidence in people is limited. What is clear is that cancer trials ask participants to avoid pregnancy, breastfeeding and fathering a child while taking cannabinoids [22]. If you are planning a family after treatment, ask your oncologist or a fertility specialist.

Does cannabis help with chemo nausea?

It helped some people in trials when added to standard anti-nausea medicines: average nausea scores were 2.11 with a THC:CBD extract against 2.99 with placebo [1]. Two prescription cannabinoids, dronabinol and nabilone, are FDA-approved for chemotherapy nausea [30]. Talk to your oncologist before changing your nausea plan.

Is it safe during chemotherapy or immunotherapy?

It depends on your drugs and your blood counts. During chemotherapy the main concerns are liver-enzyme interactions and infection risk when white cells are low [7]. During immunotherapy, lab work suggests cannabinoids may dampen immune cells, and patient studies are mixed [23][20]. Ask your oncologist about timing before you start.

Is delta-8 THC the same as medical cannabis?

No. Delta-8 THC products are usually made by chemically converting CBD and are sold outside state medical programs, often without the testing and labeling licensed dispensaries require. The FDA has not approved them, and no cannabis product other than the prescription medicines described above is FDA-approved [4]. They were not what the cancer trials on this page tested.

Does cancer have a cure?

Many cancers can be cured, especially when found early, with surgery, radiation, chemotherapy, targeted therapy or immunotherapy. Others cannot be cured but can be controlled for years. There is no single cure for all cancers, because cancer is many different diseases. Your oncologist can explain what the goal of your treatment is.

About the card

Is cancer a qualifying condition in my state?

In most states with a medical program, cancer is listed directly; in others it qualifies through symptoms such as severe nausea, chronic pain or wasting [26]. Each state keeps its own list. A licensed physician in your state checks this during the evaluation, and our state laws overview shows the rules where you live.

Can I use my card in another state?

Sometimes. Some states accept out-of-state medical cards, some accept them only with a local registration, and many do not accept them at all. Crossing state lines with cannabis remains illegal under federal law. Before you travel for treatment, check which states accept out-of-state cards.

What if I lose my card?

Contact your state program to request a replacement; most handle it online. Your physician’s recommendation stays in your account, so you do not need a new evaluation just because the card is lost. Step-by-step help is in our guide on what to do if your card was lost.

How long after the appointment do I get my recommendation?

Usually within 24 to 48 hours after the appointment, if the physician finds that you qualify. The appointment itself is a telemedicine visit with a doctor licensed in your state, held online so you do not have to travel during treatment. State registration, where required, follows on the state’s own timeline.

All card questions

Cancer support resources and the latest news

Medical cannabis is one small part of living with cancer. These trusted resources cover the rest, from finding a cancer center to finding people who understand.

  • Find a cancer center

    The National Cancer Institute keeps a directory of NCI-Designated Cancer Centers [31], organized by state, for treatment and clinical trials near you, including hematology and oncology centers. Its Cancer Information Service answers questions at 1-800-4-CANCER.

  • Support communities and helplines

    The American Cancer Society [32] and the Cancer Support Community [33] offer patient guides, support groups and help for families, in person and online.

  • Cancer awareness months and ribbon colors

    Most cancers have an awareness month and a ribbon color, such as pink for breast cancer in October. Patient organizations like the American Cancer Society [32] use them for screening reminders and fundraising.

  • Latest cannabis news

    Law changes, new state programs and research headlines, summarized for patients in our cannabis news section.

Other conditions people ask about

Symptoms of cancer and its treatment overlap with other conditions we cover in depth.

Full list of conditions

How else can we help you?

If you take three things from this page, take these.

  • Symptom relief, not a cure. The evidence is about nausea, pain, appetite and sleep during treatment.

  • Check safety and interactions first. Your medicines and blood counts decide what is safe.

  • Decide with your oncologist. Cannabis works alongside your treatment plan, never instead of it.

Talk to a physician licensed in your state

About five minutes online, then about fifteen minutes with the doctor.

Share your experience

Leave an anonymous messageTell us what this page failed to answer, or where we got something wrong. It goes to the team, not onto the page, and no account or email is needed.
Share your storyA longer account of living with this condition, written for the people who arrive at this page next. Published with your first name, or anonymously if you ask.
Write a public commentAsk a question, correct us, or answer somebody else’s question at the foot of this page. Comments are public once they clear moderation.Add a comment

    💬

    How else can we help you?

    Tell us what you’d like to see, learn, or get from us next.

    🕶️
    100% anonymous — share what’s on your mind
    We will only use it if we need to follow up on your message.

      💬

      Share Your Story with the Dr. Weedy Community

      Your positive, negative, or neutral experience can really help others. Feel free to share it in a few clear, short sentences.

      🕶️
      Your contact details are encrypted and will never be shared publicly

      References

      33 sources
      1. 1. Sukpiriyagul A, Chartchaiyarerk R, Tabtipwon P, et al. Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial. Int J Womens Health · 2023 · crossover_rct DOI: 10.2147/IJWH.S401938 PMID: 37608911
      2. 2. Grimison P, Mersiades A, Kirby A, et al. Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial. J Clin Oncol · 2024 · crossover_rct DOI: 10.1200/JCO.23.01836 PMID: 39151115
      3. 3. Creangă-Murariu I, Rezuș II, Karami R, et al. Indications of Cannabinoids for the Palliation of Cancer-Associated Symptoms: A Systematic Review and Meta-Analysis. Curr Oncol Rep · 2025 · meta_analysis DOI: 10.1007/s11912-025-01695-x PMID: 40748522
      4. 4. U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process. 2026.
      5. 5. Reddy AC, Hampton JM, Park SJ, et al. Measuring the Effects of Cannabis on Anxiety and Depression Among Cancer Patients. Cancer Med · 2025 · cohort DOI: 10.1002/cam4.71342 PMID: 41163433
      6. 6. Javid FA, Belancic A, Kwok MK, et al. Recent Advances in the Therapeutic Potential of Cannabinoids Against Gliomas: A Systematic Review (2022-2025). Pharmacol Res Perspect · 2025 · systematic_review DOI: 10.1002/prp2.70160 PMID: 40781861
      7. 7. Perri F, Marciano ML, Zotta A, et al. Medical Cannabis for Best Supportive Care of Patients Affected by Cancers of the Head and Neck: A Narrative Review. In Vivo · 2026 · narrative_review DOI: 10.21873/invivo.14172 PMID: 41482365
      8. 8. National Cancer Institute. Cancer Pain (PDQ), Patient Version. 2026.
      9. 9. Centers for Disease Control and Prevention, National Center for Health Statistics. ICD-10-CM. 2026.
      10. 10. National Cancer Institute. Nutrition During Cancer. 2026.
      11. 11. National Cancer Institute. What Is Cancer?. 2026.
      12. 12. National Cancer Institute. Infection and Neutropenia during Cancer Treatment. 2026.
      13. 13. National Cancer Institute. Cancer Staging. 2026.
      14. 14. National Cancer Institute. Common Cancer Myths and Misconceptions. 2026.
      15. 15. Szkudlarek J, Piwowarczyk L, Jelińska A Cannabidiol in Gliomas: Therapeutic Potential and Nanocarrier Strategies, with an Emphasis on Vesicular Delivery Systems. Mol Pharm · 2026 · narrative_review DOI: 10.1021/acs.molpharmaceut.5c00853 PMID: 41288593
      16. 16. Hardy JR, Greer RM, Pelecanos AM, et al. Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol. Support Care Cancer · 2025 · rct DOI: 10.1007/s00520-025-09763-5 PMID: 40705150
      17. 17. Fleege NMG, Miller EA, Kidwell KM, et al. Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Breast Cancer. Cancer Med · 2025 · clinical_trial DOI: 10.1002/cam4.71117 PMID: 40751295
      18. 18. Maan MHA, Maan S, Ahmad MM, et al. Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study. J Gastrointest Cancer · 2026 · cohort DOI: 10.1007/s12029-025-01383-w PMID: 41533288
      19. 19. Atreya CE, Leach H, Asiimwe E, et al. Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers. Am Soc Clin Oncol Educ Book · 2025 · narrative_review DOI: 10.1200/EDBK-25-471734 PMID: 39841946
      20. 20. Vigano M, Wang L, As’sadiq A, et al. Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy. Front Immunol · 2025 · narrative_review DOI: 10.3389/fimmu.2025.1497829 PMID: 40109334
      21. 21. Yee EJ, Kirsch MJ, Miller OS, et al. Cannabis, Pain, and Complications: A Prospective Analysis of Cannabis Use, Opiate Consumption, and Postoperative Outcomes following Cancer-Related Abdominal Surgery. Ann Surg Oncol · 2026 · cohort DOI: 10.1245/s10434-025-18552-7 PMID: 41131391
      22. 22. Gurgenci T, Hardy J, Huggett G, et al. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial. Trials · 2024 · rct DOI: 10.1186/s13063-024-08091-z PMID: 38693590
      23. 23. Mathibela SP, Ncube KN, Lebelo MT, et al. Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology. J Cancer Res Clin Oncol · 2025 · narrative_review DOI: 10.1007/s00432-025-06323-6 PMID: 41102423
      24. 24. Centers for Disease Control and Prevention. Cannabis and Lung Health. 2026.
      25. 25. Hardy J, Haywood A, Gogna G, et al. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Trials · 2020 · rct DOI: 10.1186/s13063-020-04541-6 PMID: 32631447
      26. 26. National Conference of State Legislatures. State Medical Cannabis Laws. 2026.
      27. 27. U.S. Equal Employment Opportunity Commission. Cancer in the Workplace and the ADA. 2026.
      28. 28. Social Security Administration. 13.00 Cancer (Malignant Neoplastic Diseases), Adult. 2026.
      29. 29. U.S. Department of Health and Human Services. HIPAA for Individuals. 2026.
      30. 30. National Cancer Institute. Cannabis and Cannabinoids (PDQ), Patient Version. 2026.
      31. 31. National Cancer Institute. Find an NCI-Designated Cancer Center. 2026.
      32. 32. American Cancer Society. American Cancer Society. 2026.
      33. 33. Cancer Support Community. Cancer Support Community. 2026.
      0 Comments
      Inline Feedbacks
      View all comments
      Security check required

      Our security system needs to verify your connection. Please reload the page and complete the quick verification — your details are safe and nothing was lost.